• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Dx Deals: Collaboration Takes Psoriasis Testing to New Level

Dx Deals: Collaboration Takes Psoriasis Testing to New Level

by Ron Shinkman | Mar 28, 2024 | Deals-lir, Essential, Lab Industry Advisor

Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Quest and Labcorp Move beyond Laboratory Testing

Dx Deals: Quest and Labcorp Move beyond Laboratory Testing

by Ron Shinkman | Mar 5, 2024 | Deals-lir, Essential, Lab Industry Advisor

Both companies have made recent moves to diversify further.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals Roundup: Pact Aims to Improve Prostate Cancer Detection Among Hispanic Males

Dx Deals Roundup: Pact Aims to Improve Prostate Cancer Detection Among Hispanic Males

by Ron Shinkman | Jan 30, 2024 | Deals-lir, Essential, Lab Industry Advisor

More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deal Roundup: Top 10 Clinical Lab M&A Deals of 2023

Dx Deal Roundup: Top 10 Clinical Lab M&A Deals of 2023

by Glenn S. Demby | Jan 9, 2024 | Deals-lir, Essential, Lab Industry Advisor

An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deal Roundup: A Major Proteomics Merger, Ginkgo Makes Pharma Inroads, and More Legal Woes for Illumina

Dx Deal Roundup: A Major Proteomics Merger, Ginkgo Makes Pharma Inroads, and More Legal Woes for Illumina

by Glenn S. Demby | Oct 24, 2023 | Deals-lir, Essential, Lab Compliance Advisor, Laboratory Industry Report, National Lab Reporter

As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com